The Microring YT is a commercial system for identifying clinical yeast isolates. The system uses a series of discs impregnated with inhibitory agents mounted on a ring. 
Methods A total of 606 yeast strains were examined, representing 13 yeast species. Three hundred and fifty five (13 species) were recent clinical isolates from patients on the intensive care unit and 251 (nine species) were environmental isolates collected from the unit over the same seven month period. Clinical specimens were collected from multiple sites from each patient-for example, throat, rectal, urine, wound, interdigital. Thirty eight (9%) clinical isolates were repeat isolates from the same site but after an interval of at least seven days.
All strains were germ tube negative. Germ tube positive isolates were not included as these would normally be identified as Candida albicans and no further identification undertaken.6 All isolates were stored on Sabouraud's glucose agar (SGA) slopes (CM 41; Oxoid Ltd, Basingstoke, United Kingdom) at room temperature and tested within six weeks of isolation. All strains were subcultured on to SGA plates to check for purity before testing. Two commercial kits were used to identify the organisms, the API 32C (API-BioMerieux, Basingstoke, United Kingdom) and the Microring YT (Medical Wire and Equipment Co Ltd, Corsham, United Kingdom).
The API 32C was performed according to the manufacturer's instructions. Kits were stored at 4°C until used. After incubation at 30°C for 48 hours the biotype number of the unknown yeast was compared with those in a database compendium supplied by the manufacturer.
With the Microring YT system, the test organism was emulsified in 3 ml sterile distilled water to give a density equivalent to a No 1-No In this study it was assumed that the identities given by the API 32C were correct, and the performance of the Microring YT was assessed against this standard.
The sensitivity and specificity of detection and the predictive value of a positive and a negative test were determined for each species identified by the Microring YT.7
Results
With the API system, 13 different species were identified among the patient isolates and nine of these were found in the enrivonment (table 1) . Only one species (Candida famata) was found exclusively in the environment so patient and environmental isolates were combined. One hundred and sixty six of the 606 germ tube negative isolates under investigation were C albicans. This represents 36% of all C albicans isolates from the study period. This proportion of germ tube negative strains is higher than might be expected, as 95-97% of clinical isolates of C albicans are germ tube positive in serum.6 This finding may result from the inclusion of more than one clinical isolate of C albicans from each patient (mean 2 6, range 1-11), especially if patients were extensively colonised with atypical strains. Nine of the 13 species identified by API 32C were included in the Microring YT database (594 of 606 isolates (98%)).
Four hundred and thirty one of the 594 isolates that were in the Microring YT database were correctly identified (72-6%) (table 1).
Thirty five (5-9%) strains could not be identified. Agreement between the API and Microring systems varied between 38 and 100% for different species; it was less than 50% for three species (Candida parapsilosis, Saccharomyces cerevisiae, and C guilliermondii) (table 1) . Notably, Candida parapsilosis gave a wide range of misidentifications but was frequently identified as Candida lusitaniae (20-9%). The predictive value of identification of some species was very poor (table 2), with three species (Candida krusei, C lusitaniae, and C famata) having values of less than 50%.
Twelve isolates belonged to species not included in the Microring YT database. Only four of these gave "no identity", eight giving "false" identification (table 3) .
Discussion
There has been one previously published evaluation of the Microring YT, where 142 isolates were examined in three laboratories.8 Only 52-8% of isolates were correctly identified in all laboratories. Our finding that 72-6% of strains were correctly identified may reflect the large numbers of commonly isolated species included in our group of isolates. We found that accurate identification of many species was a problem with the Microring YT. The method sheet supplied with the rings states that any zones, however small, should be scored as susceptible. Although a single observer read all the plates, considerable difficulty was often found in deciding whether there was total inhibition of growth around a disc. Even with experience, interpretation was sometimes very subjective. This would obviously impair reproducibility in most laboratories, where it is unlikely that the same person would read all tests. Lack of reproducibility may have contributed to the lower identification rate found in the previous study.8
The Microring YT has a limited database of only 18 species. This is smaller than other yeast identification systems34 and may be difficult to enlarge with only six tests on each ring and a limited number of discriminatory factors. The sensitivity of detection of several common species was found to be very poor with a positive predictive value of below 50%.
Compared with the API 32C, the Microring YT is very quick and simple to use, requires no special equipment, needs very little storage space and is considerably cheaper (about £0.40/test compared with £2.00/test). This is at the expense of being difficult to read, however, having a limited database and poor sensitivity for several species.
In a routine diagnostic microbiology laboratory most yeast isolates do not require full identification. In the few cases where it is important to identify accurately clinically important isolates, we feel that the performance of the Microring YT is inadequate, its advantages are outweighed by its disadvantages, and another identification method should be used.
